SCHEMBL4543199

SCHEMBL4543199

C=CCn1nc(-c2ccc(O)cc2O)c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 14/20 0.63
ESR2 Q92731 2/20 0.63
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030941 0.81 ESR1 (0.61) ESR1ESR2HSD17B10
SCHEMBL4034568 0.80 ESR1 (0.74) ESR1ESR2
SCHEMBL4035587 0.80 ESR1 (0.71) ESR1ESR2
SCHEMBL4029275 0.80 ESR1 (0.56) ESR1ESR2HSD17B10
SCHEMBL5903433 0.80 ESR1 (0.43) ESR1ESR2HSD17B10
SCHEMBL3890967 0.77 ESR1 (1.00) ESR1ESR2
SCHEMBL3622654 0.72 MAPK1 (0.46) ESR1ESR2
SCHEMBL4029316 0.72 ESR1 (0.67) ESR1ESR2HSD17B10
SCHEMBL4034586 0.71 ESR1 (1.00) ESR1ESR2
SCHEMBL4031608 0.70 ESR1 (0.72) ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7601847-B2 Via lithium bis(trimethylsilyl)amide, lithium dicyclohexylamide, or potassium bis(trimethylsilyl)amide base and alkylating agent; atherosclerosis, myocardial infarction, congestive heart failure, inflammatory bowel disease, arthritis, type II diabetes, multiple sclerosis and rheumatoid arthritis WYETH (US) 2009-10-13 US disclosed